Articles dans des revues avec comité de lecture (368)
  1. 274. Bron, D., & Jacob, F. (1995). Colony-stimulating factors: current applications and perspectives. Cancer treatment and research, 79, 245-254.
  2. 275. De Bruyn, C., Delforge, A., Bron, D., Ley, P., De Hemptinne, D., & Stryckmans, P. (1994). Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium. Stem cells, 12(6), 616-625. doi:10.1002/stem.5530120609
  3. 276. Somers, R., Carde, P., Thomas, J., Tirelli, U., Keuning, J., Bron, D., Zittoun, R., De Bock, R., De Wolf, C., van Glabbeke, M., & Duez, N. (1994). EORTC study non-hodgkin's lymphoma: Phase III study comparing CHVmP-VB vs ProMACE-MOPP in patients with stage II-III-IV intermediate and high grade lymphoma. Annals of oncology, 5(2), 85-89.
  4. 277. Lagneaux, L., Delforge, A., Snoeck, R., Stryckmans, P., & Bron, D. (1994). Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. Experimental hematology, 22(1), 26-30.
  5. 278. Bron, D. (1994). Graft-versus-host disease. Current opinion in oncology, 6(4), 358-364.
  6. 279. Lagneaux, L., Delforge, A., Dorval, C., Bron, D., & Stryckmans, P. (1993). Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. Blood, 82(8), 2379-2385. doi:10.1182/blood.v82.8.2379.bloodjournal8282379
  7. 280. Lagneaux, L., Delforge, A., Stryckmans, P., & Bron, D. (1993). Cytomegalovirus-mediated myelosuppression. Experimental hematology, 21(7), 837-838.
  8. 281. Razavi, D., Delvaux, N., Bredart, A., Autier, P., Bron, D., Debusscher, L., & Stryckmans, P. (1993). Professional rehabilitation of lymphoma patients: A study of psychosocial factors associated with return to work. Quality of life research, 2(1), 51.
  9. 282. Bron, D., Merle-Beral, H., Bernier, M., Biron, G., Leleux, A., Jacquy, C., Paesmans, M., Stryckmans, P., Fonteyn, C., Armand, M., Delespesse, G., Binet, L., & Sarfati, M. (1993). Serum soluble CD23 is a prognostic marker in chronic lymphocytic leukemia (CLL) and stage IV lymphocytic lymphoma (LL). Nouvelle revue française d'hématologie, 35(3), 328a.
  10. 283. De Bruyn, C., Stryckmans, P., Bron, D., Ley, P., Degueldre, M., & Delforge, A. (1993). Modulation de la croissance des cellules souches hématopoiétiques du sang de cordon par des facteurs de croissance. Nouvelle revue française d'hématologie, 35(3), 344a.
  11. 284. Carde, P., Hagenbeek, A., Hayat, M., Monconduit, M., Thomas, J., Burgers, M., Noordijk, E. M., Tanguy, A., Meerwaldt, J. H., Le Fur, R., Somers, R., Kluin-Nelemans, H. C., Busson, A., Breed, W., Bron, D., Holdrinet, A., Rutten, E., Michiels, J., Regnier, R., Debusscher, L., Musella, R., Fargeot, P., Thyss, A., Cattan, A., Rigal-Huguet, F., Roth, S. L., Caillou, B., Dupouy, N., & Henry-Amar, M. (1993). Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage hodgkin's disease: the H6 twin randomized trials from the european organization for research and treatment of cancer lymphoma cooperative group. Journal of clinical oncology, 11(11), 2258-2272.
  12. 285. Razavi, D., Delvaux, N., Bredart, A., Autier, P., Bron, D., Debusscher, L., & Stryckmans, P. (1993). Professional rehabilitation of lymphoma patients: a study of psychosocial factors associated with return to work. Supportive care in cancer, 1, 276-278.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>